John Hammond

Senior Scientist - Molecular Technologies @Seres Therapeutics

Cambridge, MA, US

Played a key role in development, validation, and implementation of a new clinical assay to read out drug trial results and co-authored associated manuscript.• Developed and standardized production of reference reagents which enabled a major upgrade to the whole metagenomic sequencing platform, transitioning it from relative to absolute quantification of abundances.• Identified key quality attributes and methods of evaluation. Qualified protocols and trained operators for cell enumeration to characterize and release cell reagent lots.• Optimized DNA extraction parameters to improve assay accuracy using in-house and commercial standards.Supported pre-IND design team by building and implementing a screen for spore formation by candidate species.• Literature review and collaborative work with microbiology and bioprocessing groups to define design space.• Leveraged automation and continual data monitoring for efficient execution. Presented results to program leads and other key stakeholders.

Geisel School of Medicine at Dartmouth

Doctor of Philosophy - PhD, Microbiology and Immunology

Ithaca College

Bachelor’s Degree, Biology,